NCT07060274View on ClinicalTrials.gov

Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Giant Cell Arteritis (GCA)Doppler Ultrasound
Interventions
PROCEDURE

Doppler Ultrasound

Doppler ultrasound of temporal arteries at D0, D3 and D7 (+ D15 if halo detected at D7) after initiation of corticosteroid therapy.

Trial Locations (6)

14000

CHU Caen Normandie, Caen

17000

Groupe hospitalier La Rochelle-Ré-Aunis, La Rochelle

21000

CHU Dijon - Hôpital François Mitterrand, Dijon

44000

CHU Nantes, Nantes

49100

CHU d'Angers, Angers

72000

Centre Hospitalier du Mans, Le Mans

All Listed Sponsors
lead

Centre Hospitalier le Mans

OTHER

NCT07060274 - Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients | Biotech Hunter | Biotech Hunter